BL Open Adolescents | BL Closed Adolescents | Adults | P-value | ||
---|---|---|---|---|---|
CILP-2 [ng/ml] | BL | 0.56 (−0.059, 1.2) | 0.98 (0.60, 1.4) | 1.4 (0.90, 2.0) | 0.13 |
FU | 2.2 (1.4, 3.1) | 3.0 (1.3, 4.6) | 2.6 (2.0, 3.2) | 0.775 | |
COMP [U/l] | BL | 15.2 (11.8, 18.5) | 11.5 (3.7, 19.3) | 12.8 (10.8, 14.8) | 0.406 |
FU | 15.0 (13.1, 16.8) | 12.1 (6.7, 17.6) | 13.4 (11.8, 15.0) | 0.537 | |
sC2C [ng/ml] | BL | 167.9 (108.6, 227.1) | 137.5 (18.6, 256.4) | 120.5 (90.3, 150.7) | 0.177 |
FU | 123.3 (105.8, 140.7) | 113.4 (70.2, 156.6) | 159.6 (120.0, 199.3) | 0.241 | |
CPII [ng/ml] | BL | 310.4 (212.8, 407.9) | 177.2 (−5.1, 359.5) | 199.3 (139.7, 258.9) | 0.164 |
FU | 176.9 (139.7, 214.1) | 161.8 (42.5, 281.0) | 262.9 (144.7, 381.0) | 0.862 | |
C2C-HUSA [ng/mmol] | BL | 7.4 (2.3, 12.6) | 3.6 (0.21, 7.0) | 0.43 (0.33, 0.53) | <0.001 * 0.007 ** |
FU | 3.2 (1.9, 4.5) | 1.3 (0.53, 2.0) | 0.54 (0.39, 0.69) | <0.001 * 0.112 ** | |
CTX-II [ng/mmol] | BL | 10,675.6 (6038.9, 15,312.3) | 3710.8 (259.7, 7161.9) | 255.4 (177.2, 333.7) | <0.001 * 0.030 ** |
FU | 3312.2 (2255.6, 4368.9) | 1499.8 (1181.6, 1818.1) | 281.1 (203.5, 358.7) | <0.001 * 0.034 ** |